In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
Shmelkov, E.
- Contributor
-
Krachmarov, C.
Grigoryan, A.
Agarwal, A.
Statnikov, A.
Cardozo, T.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P332
- URN
-
urn:nbn:de:1111-2016080727766
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shmelkov, E.
- Krachmarov, C.
- Grigoryan, A.
- Agarwal, A.
- Statnikov, A.
- Cardozo, T.
- SpringerLink (Online service)
Other Objects (12)
Monoclonal antibodies
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Monoclonal antibodies
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Monoclonal antibodies
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies